Patents by Inventor George H. Sands

George H. Sands has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for the treatment of migraine
    Publication number: 20030216458
    Abstract: The present invention relates to a method of treating migraine in a mammal, including a human, by administering to the mammal a 5HT1 receptor agonist in combination with caffeine and a cyclooxygenase-2 (COX-2) inhibitor. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a 5HT1 receptor agonist with caffeine a cyclooxygenase-2 (COX-2) inhibitor.
    Type: Application
    Filed: April 9, 2003
    Publication date: November 20, 2003
    Inventors: Wilma M. Harrison, George H. Sands
  • 5HT1 receptor agonists and metoclopramide for the treatment of migraine
    Publication number: 20010020036
    Abstract: The present invention relates to a method of treating migraine in a mammal, including a human, by administering to the mammal a 5HT1 receptor agonist, and particularly eletriptan, in combination with metoclopramide. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a 5HT1 receptor agonist and metoclopramide.
    Type: Application
    Filed: April 19, 2001
    Publication date: September 6, 2001
    Inventor: George H. Sands
  • 5HT 1 receptor agonists and metoclopramide for the treatment of migraine
    Patent number: 6255334
    Abstract: The present invention relates to a method of treating migraine in a mammal, including a human, by administering to the mammal a 5HT1 receptor agonist, and particularly eletriptan, in combination with metoclopramide. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a 5HT1 receptor agonist and metoclopramide.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: July 3, 2001
    Assignee: Pfizer Inc
    Inventor: George H. Sands